Cargando…
The Impact of Matrix Metalloproteinase 2 on Prognosis and Clinicopathology of Breast Cancer Patients: A Systematic Meta-Analysis
BACKGROUNDS: Matrix metalloproteinase 2 (MMP-2) plays a crucial role in the progression of breast cancer (BC). The prognostic role of MMP-2 expression in BC patients has been widely reported, but the results were inconsistent. Thus, a meta-analysis was conducted to gain a better insight into the imp...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376789/ https://www.ncbi.nlm.nih.gov/pubmed/25816052 http://dx.doi.org/10.1371/journal.pone.0121404 |
_version_ | 1782363787210260480 |
---|---|
author | Chen, Yiping Wang, Xiaochen Chen, Guodi Dong, Caixia Zhang, Depu |
author_facet | Chen, Yiping Wang, Xiaochen Chen, Guodi Dong, Caixia Zhang, Depu |
author_sort | Chen, Yiping |
collection | PubMed |
description | BACKGROUNDS: Matrix metalloproteinase 2 (MMP-2) plays a crucial role in the progression of breast cancer (BC). The prognostic role of MMP-2 expression in BC patients has been widely reported, but the results were inconsistent. Thus, a meta-analysis was conducted to gain a better insight into the impact of MMP-2 expression on survival and clinicopathological features of BC patients. METHODS: Identical search strategies were used to search relevant literatures in electronic databases update to August 1, 2014. Individual hazard ratios (HRs) and odds ratios (ORs) with their 95% confidence intervals (CIs) were extracted and pooled to evaluate the strength of the association between positive MMP-2 expression and survival results and clinicopathological features of BC patients. Begg’s tests, Egger’s tests and funnel plots were used to evaluate publication bias. Heterogeneity and sensitivity analysis were also assessed. All the work was completed using STATA. RESULTS: Pooled HRs and 95% CIs suggested that MMP-2 expression had an unfavorable impact on both OS (HR: 1.53, 95% CI: 1.29–1.82) and DFS/RFS/DDFS (HR: 1.41, 95% CI: 1.07–1.86) in BC patients. Furthermore, MMP-2 expression was significantly associated with lymph node metastasis (positive vs negative: OR 1.91, 95% CI 1.17–3.12). CONCLUSION: In conclusion, positive MMP-2 expression might be a significant predictive factor for poor prognosis in patients with BC. |
format | Online Article Text |
id | pubmed-4376789 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-43767892015-04-04 The Impact of Matrix Metalloproteinase 2 on Prognosis and Clinicopathology of Breast Cancer Patients: A Systematic Meta-Analysis Chen, Yiping Wang, Xiaochen Chen, Guodi Dong, Caixia Zhang, Depu PLoS One Research Article BACKGROUNDS: Matrix metalloproteinase 2 (MMP-2) plays a crucial role in the progression of breast cancer (BC). The prognostic role of MMP-2 expression in BC patients has been widely reported, but the results were inconsistent. Thus, a meta-analysis was conducted to gain a better insight into the impact of MMP-2 expression on survival and clinicopathological features of BC patients. METHODS: Identical search strategies were used to search relevant literatures in electronic databases update to August 1, 2014. Individual hazard ratios (HRs) and odds ratios (ORs) with their 95% confidence intervals (CIs) were extracted and pooled to evaluate the strength of the association between positive MMP-2 expression and survival results and clinicopathological features of BC patients. Begg’s tests, Egger’s tests and funnel plots were used to evaluate publication bias. Heterogeneity and sensitivity analysis were also assessed. All the work was completed using STATA. RESULTS: Pooled HRs and 95% CIs suggested that MMP-2 expression had an unfavorable impact on both OS (HR: 1.53, 95% CI: 1.29–1.82) and DFS/RFS/DDFS (HR: 1.41, 95% CI: 1.07–1.86) in BC patients. Furthermore, MMP-2 expression was significantly associated with lymph node metastasis (positive vs negative: OR 1.91, 95% CI 1.17–3.12). CONCLUSION: In conclusion, positive MMP-2 expression might be a significant predictive factor for poor prognosis in patients with BC. Public Library of Science 2015-03-27 /pmc/articles/PMC4376789/ /pubmed/25816052 http://dx.doi.org/10.1371/journal.pone.0121404 Text en © 2015 Chen et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Chen, Yiping Wang, Xiaochen Chen, Guodi Dong, Caixia Zhang, Depu The Impact of Matrix Metalloproteinase 2 on Prognosis and Clinicopathology of Breast Cancer Patients: A Systematic Meta-Analysis |
title | The Impact of Matrix Metalloproteinase 2 on Prognosis and Clinicopathology of Breast Cancer Patients: A Systematic Meta-Analysis |
title_full | The Impact of Matrix Metalloproteinase 2 on Prognosis and Clinicopathology of Breast Cancer Patients: A Systematic Meta-Analysis |
title_fullStr | The Impact of Matrix Metalloproteinase 2 on Prognosis and Clinicopathology of Breast Cancer Patients: A Systematic Meta-Analysis |
title_full_unstemmed | The Impact of Matrix Metalloproteinase 2 on Prognosis and Clinicopathology of Breast Cancer Patients: A Systematic Meta-Analysis |
title_short | The Impact of Matrix Metalloproteinase 2 on Prognosis and Clinicopathology of Breast Cancer Patients: A Systematic Meta-Analysis |
title_sort | impact of matrix metalloproteinase 2 on prognosis and clinicopathology of breast cancer patients: a systematic meta-analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376789/ https://www.ncbi.nlm.nih.gov/pubmed/25816052 http://dx.doi.org/10.1371/journal.pone.0121404 |
work_keys_str_mv | AT chenyiping theimpactofmatrixmetalloproteinase2onprognosisandclinicopathologyofbreastcancerpatientsasystematicmetaanalysis AT wangxiaochen theimpactofmatrixmetalloproteinase2onprognosisandclinicopathologyofbreastcancerpatientsasystematicmetaanalysis AT chenguodi theimpactofmatrixmetalloproteinase2onprognosisandclinicopathologyofbreastcancerpatientsasystematicmetaanalysis AT dongcaixia theimpactofmatrixmetalloproteinase2onprognosisandclinicopathologyofbreastcancerpatientsasystematicmetaanalysis AT zhangdepu theimpactofmatrixmetalloproteinase2onprognosisandclinicopathologyofbreastcancerpatientsasystematicmetaanalysis AT chenyiping impactofmatrixmetalloproteinase2onprognosisandclinicopathologyofbreastcancerpatientsasystematicmetaanalysis AT wangxiaochen impactofmatrixmetalloproteinase2onprognosisandclinicopathologyofbreastcancerpatientsasystematicmetaanalysis AT chenguodi impactofmatrixmetalloproteinase2onprognosisandclinicopathologyofbreastcancerpatientsasystematicmetaanalysis AT dongcaixia impactofmatrixmetalloproteinase2onprognosisandclinicopathologyofbreastcancerpatientsasystematicmetaanalysis AT zhangdepu impactofmatrixmetalloproteinase2onprognosisandclinicopathologyofbreastcancerpatientsasystematicmetaanalysis |